Health Technology Assessment (Sep 2009)

Rituximab for the treatment of relapsed or refractory stage III or IV follicular non-Hodgkin’s lymphoma

  • A Boland,
  • A Bagust,
  • J Hockenhull,
  • H Davis,
  • P Chu,
  • R Dickson

DOI
https://doi.org/10.3310/hta13suppl2/06
Journal volume & issue
Vol. 13, no. Suppl 2

Abstract

Read online

No abstracts available.